Additionally, we performed the in vitro suppressive assay using isolated CD4+CD25+ Treg cells from the peripheral blood and tumor tissue of NSCLC patients and isolated CD8+ T cells from the peripheral blood. The gene discussed is CD8A; the disease is neoplasm.